PALO ALTO, CALIFORNIA, June 3, 2025 – LVIS Corp, a global leader in neurological technology, proudly announces the upcoming U.S. release of NeuroMatch Elite, a major breakthrough set to revolutionize the future of epilepsy care.
NeuroMatch Elite launches with two groundbreaking capabilities – Seizure Source Localization and Spike Source Localization – making it the most advanced tool for seizure network mapping ever offered by the company.
This technology goes far beyond traditional EEG analysis. NeuroMatch Elite offers precise seizure and spike source localization, which allows clinicians to accurately pinpoint the origin and network of abnormal brain activity in 3D, down to individual seizures or spikes. This next-level functionality gives physicians an unprecedented view of brain dynamics, which will help them to design more targeted and effective treatment plans.
“NeuroMatch Elite raises the power of the scalp EEG to new levels,” said Joshuae Gallardo, MDEMU Co-Director, OSF St. Francis, Level 4 Epilepsy Center. “It has opened my eyes to new and exciting ways to look at seizure networks and epilepsy management. A step into the future for epilepsy care.”
Until now, detailed seizure network analysis often required costly, time-consuming procedures or invasive testing. NeuroMatch Elite disrupts this standard by offering high-fidelity, non-invasive mapping tools directly within a clinicians existing workflow.
Physicians will be able to:
– Visualize seizure and spike origins on a dynamic 3D brain model
– Track brain network dynamics per second or across entire seizure events
– Compare multiple seizure events side-by-side
– Overlay findings onto established Brain Atlases for deeper anatomical context
Through this level of clarity, NeuroMatch Elite is poised to dramatically improve outcomes for patients with treatment-resistant epilepsy and those preparing for surgical interventions like resection, ablation, or SEEG-guided planning.
For the first time, clinicians will have the ability to harness advanced computational models and brain network analysis to move beyond simply identifying seizure presence – and start decoding the complex architecture of epilepsy itself.
About LVIS Corporation
LVIS Corporation, headquartered in Palo Alto, California, is a leader in neurotechnology, committed to advancing patient care through innovative AI-driven solutions in neurological diagnostics and treatment. For more information or to schedule a demonstration, visit www.lviscorp.com.
Media Contact:
Amanda Gort
KCOMM
amanda@kcomm.com
949-230-4381